IBB ETF holdings (NASDAQ) | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

BlackRock Funds III 1.06 B 1.06 B 11.66%

VRTX Vertex Pharmaceuticals, Inc. 734.32 M 1.48 M 8.08%

AMGN Amgen, Inc. 711.36 M 1.96 M 7.83%

GILD Gilead Sciences, Inc. 621.79 M 4.92 M 6.84%

REGN Regeneron Pharmaceuticals, Inc. 445.87 M 715.06 K 4.91%

ARGX Argenx SE 341.58 M 368.18 K 3.76%

ALNY Alnylam Pharmaceuticals, Inc. 283.62 M 942.17 K 3.12%

NTRA Natera, Inc. 262.68 M 967.68 K 2.89%

RVMD Revolution Medicines, Inc. 252.66 M 1.35 M 2.78%

BIIB Biogen, Inc. 224.09 M 1.04 M 2.47%

ILMN Illumina, Inc. 188.03 M 1.07 M 2.07%

MRNA Moderna, Inc. 180.31 M 2.57 M 1.98%

INSM Insmed, Inc. 162.20 M 1.52 M 1.78%

ONC BeOne Medicines Ltd. 160.77 M 564.18 K 1.77%

INCY Incyte Corp. 159.00 M 1.40 M 1.75%

UTHR United Therapeutics Corp. 157.56 M 290.80 K 1.73%

ROIV Roivant Sciences Ltd. 129.59 M 3.66 M 1.43%

NBIX Neurocrine Biosciences, Inc. 117.98 M 700.05 K 1.30%

ASND Ascendis Pharma A/S 116.86 M 438.13 K 1.29%

GMAB Genmab A/S 101.67 M 3.70 M 1.12%

1
2
3
4
5
6
7
8
...
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026